Peptilogics, Inc.

Peptilogics, Inc.

Peptilogics, Inc.

Clinical-stage peptide therapeutics company. First program is focused on developing novel anti-infectives for the post-antibiotic era. Member of @AMRAlliance
Raised
$5.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$5,500,000
Venture capital (Series A) - 2017
Founders Fund Peter Thiel Stefan Roever +1
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Peptilogics, Inc. makes some noise.